Biologically Individualized Radiotherapy Based on PET: A Novel Approach to Treatment Optimization of Head and Neck
Marta Lazzeroni1,2, Ana Ureba3,2, Henning Schäfer4
1Department of Physics, Stockholm University, Stockholm, Sweden; marta.lazzeroni@fysik.su.se.
Summary
This study introduces a new radiotherapy approach for head and neck cancer, using [18F]FDG and [18F]FMISO PET scans to personalize radiation doses. This biologically individualized strategy shows promise for significantly improving tumor control probability.
Area of Science:
- Oncology
- Medical Imaging
- Radiotherapy
Background:
- Current radiotherapy often uses a standard dose for similar cancers, potentially limiting effectiveness.
- Functional imaging advances enable personalized treatment strategies based on individual tumor biology.
Purpose of the Study:
- To propose and evaluate a novel biologically individualized radiotherapy approach for head and neck squamous cell carcinoma (HNSCC).
- To combine [18F]FDG PET for clonogenic cell information and [18F]fluoromisonidazole (FMISO) PET for radiosensitivity data.
Main Methods:
- Analyzed 28 HNSCC patients using [18F]FDG and [18F]FMISO PET to create oxygen partial pressure and clonogenic cell density maps.
- Generated automated, dose-escalated radiotherapy plans targeting a 95% tumor control probability (TCP).
- Assessed plans for clinical feasibility and expected TCP.
Main Results:
- All planned dose distributions achieved over 90% TCP.
- Treatment plans met clinical feasibility criteria for organs-at-risk, demonstrating the strategy's applicability.
- The personalized approach showed potential to increase HNSCC treatment success rates.
Conclusions:
- The proposed biologically individualized radiotherapy strategy is feasible and clinically applicable for HNSCC.
- Combining [18F]FDG and [18F]FMISO PET imaging may enhance HNSCC treatment outcomes.
- This approach promises improved patient results through precise and effective radiotherapy.
